Emobot Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $189K

  • Investors
  • 6

Emobot General Information

Description

Developer of an artificial intelligence-based behavioral and emotional monitoring platform designed for diagnosing and treating mood disorders. The company's platform uses emotion-analysis technology to support continuous monitoring of depressive symptoms, assist clinicians in diagnostic evaluation, and deliver digital therapeutic interventions, enabling clinicians to improve diagnostic accuracy, supporting patients with accessible therapeutic tools, and permitting pharmaceutical companies to enhance clinical-trial evaluation and reduce development risks.

Contact Information

Website
www.emobot.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 15 rue des Halles
  • 75001 Paris
  • France
Primary Industry
Therapeutic Devices
Other Industries
Monitoring Equipment
Corporate Office
  • 15 rue des Halles
  • 75001 Paris
  • France

Emobot Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Emobot Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 10-Apr-2025 $189K Completed Generating Revenue
5. Accelerator/Incubator 11-Oct-2022 Completed Generating Revenue
4. Accelerator/Incubator 01-Apr-2022 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
2. Accelerator/Incubator $200K Completed Generating Revenue
1. Accelerator/Incubator $200K $200K Completed Generating Revenue
To view Emobot’s complete valuation and funding history, request access »

Emobot Patents

Emobot Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4831996-A1 Device for automatic adaptation over time of an adaptative therapy for a user affected by a mental disorder Pending 23-Apr-2025
WO-2026224226-A1 Device for automatic adaptation over time of an adaptative therapy for a user affected by a mental disorder Pending 23-Apr-2025
WO-2026057891-A1 Device and computer program product for assisting a diagnosis of a patient affected by a psychiatric disorder Pending 16-Sep-2024
EP-4687152-A1 Device for collecting a data from a person at risk of a psychiatric disorder Pending 01-Aug-2024
WO-2026027738-A1 Device for collecting a data from a person at risk of a psychiatric disorder Pending 01-Aug-2024 G16H50/20
To view Emobot’s complete patent history, request access »

Emobot Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Emobot Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Berkeley SkyDeck Fund Venture Capital Minority
iPEPS-ICM Accelerator/Incubator
Station F Accelerator/Incubator
21st by CentraleSupélec Accelerator/Incubator
Berkeley SkyDeck Accelerator/Incubator Minority
You’re viewing 5 of 6 investors. Get the full list »

Emobot FAQs

  • When was Emobot founded?

    Emobot was founded in 2022.

  • Where is Emobot headquartered?

    Emobot is headquartered in Paris, France.

  • What is the size of Emobot?

    Emobot has 14 total employees.

  • What industry is Emobot in?

    Emobot’s primary industry is Therapeutic Devices.

  • Is Emobot a private or public company?

    Emobot is a Private company.

  • What is the current valuation of Emobot?

    The current valuation of Emobot is .

  • What is Emobot’s current revenue?

    The current revenue for Emobot is .

  • How much funding has Emobot raised over time?

    Emobot has raised $389K.

  • Who are Emobot’s investors?

    Berkeley SkyDeck Fund, iPEPS-ICM, Station F, 21st by CentraleSupélec, and Berkeley SkyDeck are 5 of 6 investors who have invested in Emobot.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process